possess point mutations that affect the substrate binding site of isocitrate dehydrogenase. These mutations are essentially unique to gliomas, seem to represent an early step in gliomagenesis ...

many of which are known to be initiated by mutations in the enzyme isocitrate dehydrogenase (IDH). The team found that over time, these initially slow-growing tumors acquire new, cancer-driving ...